Global Stereotactic-guided Biopsy Instrument Market Insights and Forecast to 2026

Publisher Name :
Date: 14-Jul-2020
No. of pages: 114
Inquire Before Buying

Stereotactic-guided Biopsy Instrument market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stereotactic-guided Biopsy Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Stereotactic-guided Biopsy Instrument market is segmented into

- Needle-based Biopsy Instruments

- Localization Wires

- Procedure Trays

- Others

Segment by Application, the Stereotactic-guided Biopsy Instrument market is segmented into

- Breast Biopsy

- Lung Biopsy

- Colorectal Biopsy

- Prostate Biopsy

- Others

Regional and Country-level Analysis

The Stereotactic-guided Biopsy Instrument market is analysed and market size information is provided by regions (countries).

The key regions covered in the Stereotactic-guided Biopsy Instrument market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Stereotactic-guided Biopsy Instrument Market Share Analysis

Stereotactic-guided Biopsy Instrument market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Stereotactic-guided Biopsy Instrument by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Stereotactic-guided Biopsy Instrument business, the date to enter into the Stereotactic-guided Biopsy Instrument market, Stereotactic-guided Biopsy Instrument product introduction, recent developments, etc.

The major vendors covered:

- C. R. Bard, Inc. (U.S.)

- Becton, Dickinson and Company (U.S.)

- Cook Group Incorporated (U.S.)

- Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

- Argon Medical Devices (U.S.)

- B. Braun Melsungen AG (Germany)

- Cardinal Health, Inc. (U.S.)

- Olympus Corporation (Japan)

- Boston Scientific Corporation (U.S.)

- FUJIFILM Holdings Corporation (Japan)

- INRAD, Inc. (U.S.)

- Medtronic plc (Ireland)

Global Stereotactic-guided Biopsy Instrument Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Stereotactic-guided Biopsy Instrument Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Type
1.4.2 Needle-based Biopsy Instruments
1.4.3 Localization Wires
1.4.4 Procedure Trays
1.4.5 Others
1.5 Market by Application
1.5.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Application
1.5.2 Breast Biopsy
1.5.3 Lung Biopsy
1.5.4 Colorectal Biopsy
1.5.5 Prostate Biopsy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Stereotactic-guided Biopsy Instrument Market Size, Estimates and Forecasts
2.1.1 Global Stereotactic-guided Biopsy Instrument Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Stereotactic-guided Biopsy Instrument Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Stereotactic-guided Biopsy Instrument Production Estimates and Forecasts 2015-2026
2.2 Global Stereotactic-guided Biopsy Instrument, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Stereotactic-guided Biopsy Instrument Manufacturers Geographical Distribution
2.4 Key Trends for Stereotactic-guided Biopsy Instrument Markets & Products
2.5 Primary Interviews with Key Stereotactic-guided Biopsy Instrument Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Production Capacity
3.1.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Production (2015-2020)
3.1.3 Global Top Stereotactic-guided Biopsy Instrument Manufacturers Market Share by Production
3.2 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue
3.2.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Stereotactic-guided Biopsy Instrument Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Stereotactic-guided Biopsy Instrument Revenue in 2019
3.3 Global Stereotactic-guided Biopsy Instrument Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Stereotactic-guided Biopsy Instrument Production by Regions
4.1 Global Stereotactic-guided Biopsy Instrument Historic Market Facts & Figures by Regions
4.1.1 Global Top Stereotactic-guided Biopsy Instrument Regions by Production (2015-2020)
4.1.2 Global Top Stereotactic-guided Biopsy Instrument Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Stereotactic-guided Biopsy Instrument Production (2015-2020)
4.2.2 North America Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Stereotactic-guided Biopsy Instrument Production (2015-2020)
4.3.2 Europe Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
4.4 China
4.4.1 China Stereotactic-guided Biopsy Instrument Production (2015-2020)
4.4.2 China Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Stereotactic-guided Biopsy Instrument Production (2015-2020)
4.5.2 Japan Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
5 Stereotactic-guided Biopsy Instrument Consumption by Region
5.1 Global Top Stereotactic-guided Biopsy Instrument Regions by Consumption
5.1.1 Global Top Stereotactic-guided Biopsy Instrument Regions by Consumption (2015-2020)
5.1.2 Global Top Stereotactic-guided Biopsy Instrument Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Stereotactic-guided Biopsy Instrument Consumption by Application
5.2.2 North America Stereotactic-guided Biopsy Instrument Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Stereotactic-guided Biopsy Instrument Consumption by Application
5.3.2 Europe Stereotactic-guided Biopsy Instrument Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Application
5.4.2 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Stereotactic-guided Biopsy Instrument Consumption by Application
5.5.2 Central & South America Stereotactic-guided Biopsy Instrument Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption by Application
5.6.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Stereotactic-guided Biopsy Instrument Market Size by Type (2015-2020)
6.1.1 Global Stereotactic-guided Biopsy Instrument Production by Type (2015-2020)
6.1.2 Global Stereotactic-guided Biopsy Instrument Revenue by Type (2015-2020)
6.1.3 Stereotactic-guided Biopsy Instrument Price by Type (2015-2020)
6.2 Global Stereotactic-guided Biopsy Instrument Market Forecast by Type (2021-2026)
6.2.1 Global Stereotactic-guided Biopsy Instrument Production Forecast by Type (2021-2026)
6.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Type (2021-2026)
6.2.3 Global Stereotactic-guided Biopsy Instrument Price Forecast by Type (2021-2026)
6.3 Global Stereotactic-guided Biopsy Instrument Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Stereotactic-guided Biopsy Instrument Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Stereotactic-guided Biopsy Instrument Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 C. R. Bard, Inc. (U.S.)
8.1.1 C. R. Bard, Inc. (U.S.) Corporation Information
8.1.2 C. R. Bard, Inc. (U.S.) Overview
8.1.3 C. R. Bard, Inc. (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 C. R. Bard, Inc. (U.S.) Product Description
8.1.5 C. R. Bard, Inc. (U.S.) Related Developments
8.2 Becton, Dickinson and Company (U.S.)
8.2.1 Becton, Dickinson and Company (U.S.) Corporation Information
8.2.2 Becton, Dickinson and Company (U.S.) Overview
8.2.3 Becton, Dickinson and Company (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Becton, Dickinson and Company (U.S.) Product Description
8.2.5 Becton, Dickinson and Company (U.S.) Related Developments
8.3 Cook Group Incorporated (U.S.)
8.3.1 Cook Group Incorporated (U.S.) Corporation Information
8.3.2 Cook Group Incorporated (U.S.) Overview
8.3.3 Cook Group Incorporated (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Cook Group Incorporated (U.S.) Product Description
8.3.5 Cook Group Incorporated (U.S.) Related Developments
8.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
8.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
8.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Overview
8.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Product Description
8.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Related Developments
8.5 Argon Medical Devices (U.S.)
8.5.1 Argon Medical Devices (U.S.) Corporation Information
8.5.2 Argon Medical Devices (U.S.) Overview
8.5.3 Argon Medical Devices (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Argon Medical Devices (U.S.) Product Description
8.5.5 Argon Medical Devices (U.S.) Related Developments
8.6 B. Braun Melsungen AG (Germany)
8.6.1 B. Braun Melsungen AG (Germany) Corporation Information
8.6.2 B. Braun Melsungen AG (Germany) Overview
8.6.3 B. Braun Melsungen AG (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 B. Braun Melsungen AG (Germany) Product Description
8.6.5 B. Braun Melsungen AG (Germany) Related Developments
8.7 Cardinal Health, Inc. (U.S.)
8.7.1 Cardinal Health, Inc. (U.S.) Corporation Information
8.7.2 Cardinal Health, Inc. (U.S.) Overview
8.7.3 Cardinal Health, Inc. (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Cardinal Health, Inc. (U.S.) Product Description
8.7.5 Cardinal Health, Inc. (U.S.) Related Developments
8.8 Olympus Corporation (Japan)
8.8.1 Olympus Corporation (Japan) Corporation Information
8.8.2 Olympus Corporation (Japan) Overview
8.8.3 Olympus Corporation (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Olympus Corporation (Japan) Product Description
8.8.5 Olympus Corporation (Japan) Related Developments
8.9 Boston Scientific Corporation (U.S.)
8.9.1 Boston Scientific Corporation (U.S.) Corporation Information
8.9.2 Boston Scientific Corporation (U.S.) Overview
8.9.3 Boston Scientific Corporation (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Boston Scientific Corporation (U.S.) Product Description
8.9.5 Boston Scientific Corporation (U.S.) Related Developments
8.10 FUJIFILM Holdings Corporation (Japan)
8.10.1 FUJIFILM Holdings Corporation (Japan) Corporation Information
8.10.2 FUJIFILM Holdings Corporation (Japan) Overview
8.10.3 FUJIFILM Holdings Corporation (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 FUJIFILM Holdings Corporation (Japan) Product Description
8.10.5 FUJIFILM Holdings Corporation (Japan) Related Developments
8.11 INRAD, Inc. (U.S.)
8.11.1 INRAD, Inc. (U.S.) Corporation Information
8.11.2 INRAD, Inc. (U.S.) Overview
8.11.3 INRAD, Inc. (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 INRAD, Inc. (U.S.) Product Description
8.11.5 INRAD, Inc. (U.S.) Related Developments
8.12 Medtronic plc (Ireland)
8.12.1 Medtronic plc (Ireland) Corporation Information
8.12.2 Medtronic plc (Ireland) Overview
8.12.3 Medtronic plc (Ireland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Medtronic plc (Ireland) Product Description
8.12.5 Medtronic plc (Ireland) Related Developments
9 Stereotactic-guided Biopsy Instrument Production Forecast by Regions
9.1 Global Top Stereotactic-guided Biopsy Instrument Regions Forecast by Revenue (2021-2026)
9.2 Global Top Stereotactic-guided Biopsy Instrument Regions Forecast by Production (2021-2026)
9.3 Key Stereotactic-guided Biopsy Instrument Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Stereotactic-guided Biopsy Instrument Consumption Forecast by Region
10.1 Global Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
10.2 North America Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
10.3 Europe Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
10.5 Latin America Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Stereotactic-guided Biopsy Instrument Sales Channels
11.2.2 Stereotactic-guided Biopsy Instrument Distributors
11.3 Stereotactic-guided Biopsy Instrument Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Stereotactic-guided Biopsy Instrument Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Stereotactic-guided Biopsy Instrument Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Stereotactic-guided Biopsy Instrument Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Stereotactic-guided Biopsy Instrument Key Market Segments in This Study
Table 2. Ranking of Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Needle-based Biopsy Instruments
Table 5. Major Manufacturers of Localization Wires
Table 6. Major Manufacturers of Procedure Trays
Table 7. Major Manufacturers of Others
Table 8. Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Stereotactic-guided Biopsy Instrument Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 10. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 11. Global Stereotactic-guided Biopsy Instrument by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stereotactic-guided Biopsy Instrument as of 2019)
Table 12. Stereotactic-guided Biopsy Instrument Manufacturing Base Distribution and Headquarters
Table 13. Manufacturers Stereotactic-guided Biopsy Instrument Product Offered
Table 14. Date of Manufacturers Enter into Stereotactic-guided Biopsy Instrument Market
Table 15. Key Trends for Stereotactic-guided Biopsy Instrument Markets & Products
Table 16. Main Points Interviewed from Key Stereotactic-guided Biopsy Instrument Players
Table 17. Global Stereotactic-guided Biopsy Instrument Production Capacity by Manufacturers (2015-2020) (K Units)
Table 18. Global Stereotactic-guided Biopsy Instrument Production Share by Manufacturers (2015-2020)
Table 19. Stereotactic-guided Biopsy Instrument Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2015-2020)
Table 21. Stereotactic-guided Biopsy Instrument Price by Manufacturers 2015-2020 (USD/Unit)
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stereotactic-guided Biopsy Instrument Production by Regions (2015-2020) (K Units)
Table 24. Global Stereotactic-guided Biopsy Instrument Production Market Share by Regions (2015-2020)
Table 25. Global Stereotactic-guided Biopsy Instrument Revenue by Regions (2015-2020) (US$ Million)
Table 26. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Regions (2015-2020)
Table 27. Key Stereotactic-guided Biopsy Instrument Players in North America
Table 28. Import & Export of Stereotactic-guided Biopsy Instrument in North America (K Units)
Table 29. Key Stereotactic-guided Biopsy Instrument Players in Europe
Table 30. Import & Export of Stereotactic-guided Biopsy Instrument in Europe (K Units)
Table 31. Key Stereotactic-guided Biopsy Instrument Players in China
Table 32. Import & Export of Stereotactic-guided Biopsy Instrument in China (K Units)
Table 33. Key Stereotactic-guided Biopsy Instrument Players in Japan
Table 34. Import & Export of Stereotactic-guided Biopsy Instrument in Japan (K Units)
Table 35. Global Stereotactic-guided Biopsy Instrument Consumption by Regions (2015-2020) (K Units)
Table 36. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Regions (2015-2020)
Table 37. North America Stereotactic-guided Biopsy Instrument Consumption by Application (2015-2020) (K Units)
Table 38. North America Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)
Table 39. Europe Stereotactic-guided Biopsy Instrument Consumption by Application (2015-2020) (K Units)
Table 40. Europe Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)
Table 41. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Application (2015-2020) (K Units)
Table 42. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Market Share by Application (2015-2020) (K Units)
Table 43. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Regions (2015-2020) (K Units)
Table 44. Latin America Stereotactic-guided Biopsy Instrument Consumption by Application (2015-2020) (K Units)
Table 45. Latin America Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)
Table 46. Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption by Application (2015-2020) (K Units)
Table 47. Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption by Countries (2015-2020) (K Units)
Table 48. Global Stereotactic-guided Biopsy Instrument Production by Type (2015-2020) (K Units)
Table 49. Global Stereotactic-guided Biopsy Instrument Production Share by Type (2015-2020)
Table 50. Global Stereotactic-guided Biopsy Instrument Revenue by Type (2015-2020) (Million US$)
Table 51. Global Stereotactic-guided Biopsy Instrument Revenue Share by Type (2015-2020)
Table 52. Stereotactic-guided Biopsy Instrument Price by Type 2015-2020 (USD/Unit)
Table 53. Global Stereotactic-guided Biopsy Instrument Consumption by Application (2015-2020) (K Units)
Table 54. Global Stereotactic-guided Biopsy Instrument Consumption Share by Application (2015-2020)
Table 55. C. R. Bard, Inc. (U.S.) Corporation Information
Table 56. C. R. Bard, Inc. (U.S.) Description and Major Businesses
Table 57. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 58. C. R. Bard, Inc. (U.S.) Product
Table 59. C. R. Bard, Inc. (U.S.) Recent Development
Table 60. Becton, Dickinson and Company (U.S.) Corporation Information
Table 61. Becton, Dickinson and Company (U.S.) Description and Major Businesses
Table 62. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Becton, Dickinson and Company (U.S.) Product
Table 64. Becton, Dickinson and Company (U.S.) Recent Development
Table 65. Cook Group Incorporated (U.S.) Corporation Information
Table 66. Cook Group Incorporated (U.S.) Description and Major Businesses
Table 67. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Cook Group Incorporated (U.S.) Product
Table 69. Cook Group Incorporated (U.S.) Recent Development
Table 70. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
Table 71. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Major Businesses
Table 72. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Product
Table 74. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Development
Table 75. Argon Medical Devices (U.S.) Corporation Information
Table 76. Argon Medical Devices (U.S.) Description and Major Businesses
Table 77. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Argon Medical Devices (U.S.) Product
Table 79. Argon Medical Devices (U.S.) Recent Development
Table 80. B. Braun Melsungen AG (Germany) Corporation Information
Table 81. B. Braun Melsungen AG (Germany) Description and Major Businesses
Table 82. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. B. Braun Melsungen AG (Germany) Product
Table 84. B. Braun Melsungen AG (Germany) Recent Development
Table 85. Cardinal Health, Inc. (U.S.) Corporation Information
Table 86. Cardinal Health, Inc. (U.S.) Description and Major Businesses
Table 87. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Cardinal Health, Inc. (U.S.) Product
Table 89. Cardinal Health, Inc. (U.S.) Recent Development
Table 90. Olympus Corporation (Japan) Corporation Information
Table 91. Olympus Corporation (Japan) Description and Major Businesses
Table 92. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Olympus Corporation (Japan) Product
Table 94. Olympus Corporation (Japan) Recent Development
Table 95. Boston Scientific Corporation (U.S.) Corporation Information
Table 96. Boston Scientific Corporation (U.S.) Description and Major Businesses
Table 97. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Boston Scientific Corporation (U.S.) Product
Table 99. Boston Scientific Corporation (U.S.) Recent Development
Table 100. FUJIFILM Holdings Corporation (Japan) Corporation Information
Table 101. FUJIFILM Holdings Corporation (Japan) Description and Major Businesses
Table 102. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. FUJIFILM Holdings Corporation (Japan) Product
Table 104. FUJIFILM Holdings Corporation (Japan) Recent Development
Table 105. INRAD, Inc. (U.S.) Corporation Information
Table 106. INRAD, Inc. (U.S.) Description and Major Businesses
Table 107. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. INRAD, Inc. (U.S.) Product
Table 109. INRAD, Inc. (U.S.) Recent Development
Table 110. Medtronic plc (Ireland) Corporation Information
Table 111. Medtronic plc (Ireland) Description and Major Businesses
Table 112. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Medtronic plc (Ireland) Product
Table 114. Medtronic plc (Ireland) Recent Development
Table 115. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Region (2021-2026) (Million US$)
Table 116. Global Stereotactic-guided Biopsy Instrument Production Forecast by Regions (2021-2026) (K Units)
Table 117. Global Stereotactic-guided Biopsy Instrument Production Forecast by Type (2021-2026) (K Units)
Table 118. Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Type (2021-2026) (Million US$)
Table 119. North America Stereotactic-guided Biopsy Instrument Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Europe Stereotactic-guided Biopsy Instrument Consumption Forecast by Regions (2021-2026) (K Units)
Table 121. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Forecast by Regions (2021-2026) (K Units)
Table 122. Latin America Stereotactic-guided Biopsy Instrument Consumption Forecast by Regions (2021-2026) (K Units)
Table 123. Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption Forecast by Regions (2021-2026) (K Units)
Table 124. Stereotactic-guided Biopsy Instrument Distributors List
Table 125. Stereotactic-guided Biopsy Instrument Customers List
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Stereotactic-guided Biopsy Instrument Product Picture
Figure 2. Global Stereotactic-guided Biopsy Instrument Production Market Share by Type in 2020 & 2026
Figure 3. Needle-based Biopsy Instruments Product Picture
Figure 4. Localization Wires Product Picture
Figure 5. Procedure Trays Product Picture
Figure 6. Others Product Picture
Figure 7. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2020 & 2026
Figure 8. Breast Biopsy
Figure 9. Lung Biopsy
Figure 10. Colorectal Biopsy
Figure 11. Prostate Biopsy
Figure 12. Others
Figure 13. Stereotactic-guided Biopsy Instrument Report Years Considered
Figure 14. Global Stereotactic-guided Biopsy Instrument Revenue 2015-2026 (Million US$)
Figure 15. Global Stereotactic-guided Biopsy Instrument Production Capacity 2015-2026 (K Units)
Figure 16. Global Stereotactic-guided Biopsy Instrument Production 2015-2026 (K Units)
Figure 17. Global Stereotactic-guided Biopsy Instrument Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 18. Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Stereotactic-guided Biopsy Instrument Production Share by Manufacturers in 2015
Figure 20. The Top 10 and Top 5 Players Market Share by Stereotactic-guided Biopsy Instrument Revenue in 2019
Figure 21. Global Stereotactic-guided Biopsy Instrument Production Market Share by Region (2015-2020)
Figure 22. Stereotactic-guided Biopsy Instrument Production Growth Rate in North America (2015-2020) (K Units)
Figure 23. Stereotactic-guided Biopsy Instrument Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 24. Stereotactic-guided Biopsy Instrument Production Growth Rate in Europe (2015-2020) (K Units)
Figure 25. Stereotactic-guided Biopsy Instrument Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 26. Stereotactic-guided Biopsy Instrument Production Growth Rate in China (2015-2020) (K Units)
Figure 27. Stereotactic-guided Biopsy Instrument Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 28. Stereotactic-guided Biopsy Instrument Production Growth Rate in Japan (2015-2020) (K Units)
Figure 29. Stereotactic-guided Biopsy Instrument Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 30. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Regions 2015-2020
Figure 31. North America Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. North America Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2019
Figure 33. North America Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019
Figure 34. U.S. Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Canada Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. Europe Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. Europe Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2019
Figure 38. Europe Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019
Figure 39. Germany Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. France Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. U.K. Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Italy Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 43. Russia Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (K Units)
Figure 45. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2019
Figure 46. Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Market Share by Regions in 2019
Figure 47. China Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Japan Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. South Korea Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. India Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Australia Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Malaysia Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Philippines Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 57. Vietnam Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Latin America Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (K Units)
Figure 59. Latin America Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2019
Figure 60. Latin America Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019
Figure 61. Mexico Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Brazil Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 63. Argentina Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (K Units)
Figure 65. Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption Market Share by Application in 2019
Figure 66. Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption Market Share by Countries in 2019
Figure 67. Turkey Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Saudi Arabia Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 69. U.A.E Stereotactic-guided Biopsy Instrument Consumption and Growth Rate (2015-2020) (K Units)
Figure 70. Global Stereotactic-guided Biopsy Instrument Production Market Share by Type (2015-2020)
Figure 71. Global Stereotactic-guided Biopsy Instrument Production Market Share by Type in 2019
Figure 72. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2015-2020)
Figure 73. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type in 2019
Figure 74. Global Stereotactic-guided Biopsy Instrument Production Market Share Forecast by Type (2021-2026)
Figure 75. Global Stereotactic-guided Biopsy Instrument Revenue Market Share Forecast by Type (2021-2026)
Figure 76. Global Stereotactic-guided Biopsy Instrument Market Share by Price Range (2015-2020)
Figure 77. Global Stereotactic-guided Biopsy Instrument Consumption Market Share by Application (2015-2020)
Figure 78. Global Stereotactic-guided Biopsy Instrument Value (Consumption) Market Share by Applicat
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs